(Q40111076)

17 September 2017

1 reference

title

Evidence for an effect of antithyroid drugs on the natural history of Graves' disease (English)

1 reference

17 September 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1984.TB03456.X

28 August 2023

1

Weetman AP

1 reference

17 September 2017

A. P. Weetman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6205795

28 August 2023

A. M. McGregor

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6205795

28 August 2023

R. Hall

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6205795

28 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6205795

28 August 2023

publication date

1 August 1984

1 reference

full work available at URL

17 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2265.1984.tb03456.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1984.TB03456.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2265.1984.tb03456.x/fullpdf

28 August 2023

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1984.TB03456.X

28 August 2023

published in

Clinical Endocrinology

1 reference

17 September 2017

volume

21

1 reference

17 September 2017

issue

2

1 reference

17 September 2017

page(s)

163-172

1 reference

Influence of iodine intake after treatment with antithyroid drugs.

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1984.TB03456.X

Value of thyroid-stimulating-antibody determinations in predicting short-term thyrotoxic relapse in Graves' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1984.TB03456.X

Propranolol as Primary Therapy for Thyrotoxicosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1984.TB03456.X

Histometry of lymphoid infiltrate in the thyroid of primary thyrotoxicosis patients. Relation of extent of thyroiditis to preoperative drug treatment and postoperative hypothyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1984.TB03456.X

Development of thyroidal suppression by triiodothyronine during six months' treatment of thyrotoxicosis with antithyroid drugs

21 January 2018

2

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1984.TB03456.X

Sequential assessment during drug treatment of thyrotoxicosis.

28 August 2023

3

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1984.TB03456.X

A prospective study of the relationship between relapse of hyperthyroid Graves' disease after antithyroid drugs and HLA haplotype

28 August 2023

4

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1984.TB03456.X

T lymphocyte subpopulations in Graves' disease: relationship with clinical conditions

28 August 2023

6

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1984.TB03456.X

28 August 2023

7

52

629

BONNYNS M.

1983

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1984.TB03456.X

Thyroid Hormone and Immunological Studies in Endemic Goiter*

28 August 2023

8

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1984.TB03456.X

Changes in Thyroid-Stimulating Immunoglobulins during Antithyroid Therapy*

28 August 2023

11

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1984.TB03456.X

Studies of thyroid function using 99Tcm in thyrotoxic patients during treatment with antithyroid drugs

28 August 2023

12

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1984.TB03456.X

Short-Term Antithyroid Drug Therapy for the Thyrotoxicosis of Graves's Disease

28 August 2023

13

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1984.TB03456.X

Long-term outcome of hyperthyroidism treated with antithyroid drugs

28 August 2023

15

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1984.TB03456.X

T Lymphocyte Subsets in Autoimmune Thyroid Diseases and Subacute Thyroiditis Detected with Monoclonal Antibodies*

28 August 2023

17

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1984.TB03456.X

Intrathyroidal concentrations of methimazole in patients with Graves' disease

28 August 2023

18

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1984.TB03456.X

Correlation between Thyroid Stimulators and 3,5,3′-Triiodothyronine Suppressibility in Patients during Treatment for Hyperthyroidism with Thionamide Drugs:Comparison of Assays by Thyroid-Stimulating and Thyrotropin-Displacing Activities*

28 August 2023

19

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1984.TB03456.X

HLA-and Gm-linked genes affecting the degradation rate of antigens (sheep red blood cells) endocytized by macrophages

28 August 2023

20

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1984.TB03456.X

Thyroid suppressibility: follow-up for two years after antithyroid treatment

28 August 2023

22

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1984.TB03456.X

Carbimazole and the Autoimmune Response in Graves' Disease

28 August 2023

24

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1984.TB03456.X

Carbimazole and autoantibody synthesis in Hashimoto's thyroiditis

28 August 2023

25

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1984.TB03456.X

Prediction of relapse in hyperthyroid Graves' disease

28 August 2023

26

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1984.TB03456.X

Specificity of the immunosuppressive action of carbimazole in Graves's disease

28 August 2023

27

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1984.TB03456.X

Remission of thyrotoxicosis during treatment with propranolol.

28 August 2023

28

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1984.TB03456.X

Effect of hypo- and hyperthyroidism on the balance between helper and suppressor T cells in rats

28 August 2023

30

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1984.TB03456.X

Effects of antithyroid therapy on the long-acting thyroid stimulator and the antithyroglobulin antibodies

28 August 2023

32

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1984.TB03456.X

The influence of methimazole on thyroglobulin-induced autoimmune thyroiditis in the rat

28 August 2023

33

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1984.TB03456.X

Comparison of Effects of High and Low Dosage Regimens of Antithyroid Drugs in the Management of Graves’ Hyperthyroidism*

28 August 2023

34

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1984.TB03456.X

HLA-DR3 and HLA-DR5 Associated Thyrotoxicosis-Two Different Types of Toxic Diffuse Goiter*

28 August 2023

36

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1984.TB03456.X

28 August 2023

37

22

249

SIMPSON J.G.

1975

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1984.TB03456.X

Thionamide therapy in Graves' disease: relation of relapse rate to duration of therapy

28 August 2023

39

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1984.TB03456.X

Thyrotrophin-binding Inhibitory Immunoglobulin and HLA-DRW3-Two Prognostic Factors in Graves' Disease*

28 August 2023

40

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1984.TB03456.X

The spectrum of thyroid disease in a community: the Whickham survey

28 August 2023

43

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1984.TB03456.X

Circulating immune complexes and thyroid-stimulating immunoglobulins before, during, and after antithyroid drug therapy in patients with Graves' disease

28 August 2023

44

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1984.TB03456.X

Effects of experimental hyper- and hypothyroidism on numbers of blood mononuclear cells and immune function in rats and guinea-pigs

28 August 2023

46

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1984.TB03456.X

Peripheral blood and intrathyroidal mononuclear cell populations in patients with autoimmune thyroid disorders enumerated using monoclonal antibodies

28 August 2023

47

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1984.TB03456.X

Low remission after therapy for Graves disease. Possible relation of dietary iodine with antithyroid therapy results

28 August 2023

48

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1984.TB03456.X

28 August 2023

49

50

51

WEETMAN A.P.

1982

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1984.TB03456.X

28 August 2023

50

48

196

WEETMAN A.P.

1982

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1984.TB03456.X

Methimazole inhibits thyroid autoantibody production by an action on accessory cells

28 August 2023

51

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1984.TB03456.X

Iodide enhances IgG synthesis by human peripheral blood lymphocytes in vitro

28 August 2023

52

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1984.TB03456.X

Effect of tri-iodothyronine on normal human lymphocyte function

28 August 2023

53

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1984.TB03456.X

Methimazole and generation of oxygen radicals by monocytes: potential role in immunosuppression.

28 August 2023

54

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1984.TB03456.X

28 August 2023

55

56

330

WEETMAN A.P.

1984

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1984.TB03456.X

Immunosuppression by perchlorate

28 August 2023

56

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1984.TB03456.X

28 August 2023

58

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1984.TB03456.X

Mode of action of carbimazole in Graves' disease

28 August 2023

61

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1984.TB03456.X

Hypothyroidism as a Late Sequela in Patients with Graves' Disease Treated with Antithyroid Agents

28 August 2023

62

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1984.TB03456.X

28 August 2023

Identifiers

1 reference

17 September 2017

1 reference